<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Complications of endoscopic esophageal stricture dilation</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Complications of endoscopic esophageal stricture dilation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Complications of endoscopic esophageal stricture dilation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Moises Guelrud, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John R Saltzman, MD, FACP, FACG, FASGE, AGAF</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 02, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The treatment of benign esophageal strictures typically involves dilation combined with acid suppressive therapy. Advances in endoscopic equipment and dilators have improved the safety of esophageal dilation [<a href="#rid1">1</a>], but esophageal dilation may lead to complications even in the most experienced hands. Awareness of the complications associated with dilation permits early recognition and reduces morbidity and mortality.</p><p>This topic will review the major complications associated with esophageal stricture dilation. The techniques used for the dilation of benign esophageal strictures, the approach to patients with non-iatrogenic esophageal perforations, and the complications associated with upper endoscopy in general are discussed separately. </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2270.html" rel="external">"Endoscopic interventions for nonmalignant esophageal strictures in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2260.html" rel="external">"Boerhaave syndrome: Effort rupture of the esophagus"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15062.html" rel="external">"Overview of esophageal injury due to blunt or penetrating trauma in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/13928.html" rel="external">"Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">ESOPHAGEAL PERFORATION</span><span class="headingEndMark"> — </span>The major complication of esophageal dilation is esophageal perforation, which is associated with a mortality rate of approximately 20 percent [<a href="#rid2">2</a>]. The incidence of perforation is influenced by the etiology of the stricture, the experience of the endoscopist, and the techniques and equipment used. In general, perforation rates associated with esophageal stricture dilation are low, unlike procedures such as pneumatic dilation for achalasia, where perforations are estimated to complicate three to five percent of procedures. (See  <a class="medical medical_review" href="/d/html/2245.html" rel="external">"Pneumatic dilation and botulinum toxin injection for achalasia", section on 'Esophageal perforation'</a>.)</p><p>Studies suggest that the perforation rate associated with the dilation of benign strictures is between 0.1 and 0.3 percent [<a href="#rid3">3-8</a>]. The perforation rate was 0.1 percent per session in a report from 1999 that looked at 1043 dilation sessions using Eder-Puestow or Savary dilators in 153 patients (over half of whom had peptic strictures) [<a href="#rid4">4</a>]. </p><p>In contrast, the perforation rate associated with dilation of pharyngeal strictures may be higher. In a cohort study of 477 patients with pharyngeal stenosis after total laryngectomy who underwent a total of 968 dilatation sessions, the perforation rate was 0.6 percent [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/d/html/3365.html" rel="external">"Management of late complications of head and neck cancer and its treatment", section on 'Dysphagia'</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Several risk factors for esophageal perforation have been recognized, although the magnitude of risk is uncertain [<a href="#rid5">5,10-14</a>]. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>A malignant stricture</p><p class="bulletIndent1"><span class="glyph">●</span>Severe esophagitis</p><p class="bulletIndent1"><span class="glyph">●</span>Prior radiation therapy</p><p class="bulletIndent1"><span class="glyph">●</span>A history of caustic ingestion</p><p class="bulletIndent1"><span class="glyph">●</span>Complex (tortuous) or long strictures</p><p class="bulletIndent1"><span class="glyph">●</span>Presence of esophageal diverticula</p><p class="bulletIndent1"><span class="glyph">●</span>Inexperienced operator</p><p class="bulletIndent1"><span class="glyph">●</span>A large hiatal hernia</p><p class="bulletIndent1"><span class="glyph">●</span>Use of high inflation pressures with balloon dilation</p><p class="bulletIndent1"><span class="glyph">●</span>A history of previous esophageal perforation</p><p class="bulletIndent1"><span class="glyph">●</span>A history of prior esophageal surgery (such as for trauma or a congenital abnormality)</p><p></p><p>Eosinophilic esophagitis has generally been considered a risk factor for deep mucosal tears and esophageal perforation [<a href="#rid15">15-18</a>]. However, studies examining whether patients with eosinophilic esophagitis are at increased risk have had variable results, and we believe it is prudent to continue to view patients with eosinophilic esophagitis as being at increased risk for perforation (see  <a class="medical medical_review" href="/d/html/2247.html" rel="external">"Treatment of eosinophilic esophagitis (EoE)", section on 'Esophageal dilation'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>In a meta-analysis of 37 studies including 977 patients with eosinophilic esophagitis and over 2000 dilations, perforation occurred in nine patients (0.03 percent). It was concluded that perforation from esophageal dilation in eosinophilic esophagitis is rare, and esophageal dilation should be considered a safe procedure in these patients [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A systematic review found only one perforation associated with 671 esophageal dilations (0.1 percent) in patients with eosinophilic esophagitis, a rate that is similar to the expected perforation rate for patients without eosinophilic esophagitis [<a href="#rid20">20</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>However, an increased perforation rate was noted in a study in which there were three perforations among 293 dilations (1 percent) [<a href="#rid16">16</a>]. </p><p></p><p class="headingAnchor" id="H4"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>The majority of patients with an esophageal perforation present for evaluation within 24 hours of the injury, though in some cases the presentation may be delayed [<a href="#rid21">21</a>]. The clinical features of esophageal perforation depend upon the location of the perforation (cervical, intrathoracic, or intra-abdominal), the degree of leakage, and the time elapsed since the injury occurred. Cervical perforations are typically less severe than intrathoracic or intra-abdominal perforations, though contamination of the mediastinum can occur [<a href="#rid2">2</a>].</p><p>The most common symptom is pain, occurring in more than 70 percent of patients with intrathoracic perforations [<a href="#rid22">22</a>]. Patients may develop tachycardia, tachypnea, and fever, which can progress rapidly to sepsis and shock. Auscultation of the chest in patients with mediastinal emphysema (pneumomediastinum) may reveal a crunching noise ("Hamman's sign"). </p><p>Additional signs and symptoms may include:</p><p class="bulletIndent1"><span class="glyph">●</span>Cervical perforation may be associated with neck pain, tenderness of the sternocleidomastoid muscle, dysphonia, hoarseness, cervical dysphagia, and cervical subcutaneous emphysema.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intrathoracic perforation results in contamination of the mediastinum and may also extend into the pleural cavity (most often on the left). It is most commonly associated with chest, back, or epigastric pain that is exacerbated with inspiration and swallowing. Patients may also have dysphagia, odynophagia, dyspnea, hematemesis, cyanosis, and, rarely, pericardial tamponade if the perforation involves the posterior pericardium. Mediastinal inflammation may eventually result in cervical subcutaneous emphysema. Due to negative intrathoracic pressure, gastric contents and bacteria may be drawn into the pleural space. Patients may develop signs of sepsis and shock within hours.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intra-abdominal perforation results in contamination of the peritoneal cavity. Patients may report back pain and an inability to lie supine. In addition, patients often report epigastric pain that may radiate to the shoulder. Patients may also present with an acute (surgical) abdomen. As with intrathoracic perforation, patients may rapidly deteriorate. </p><p></p><p>The laboratory evaluation may reveal a leukocytosis. While not part of the diagnostic workup for an esophageal perforation, pleural fluid collected during thoracentesis may contain undigested food, have a pH less than 6, or have an elevated salivary amylase level [<a href="#rid23">23,24</a>].</p><p class="headingAnchor" id="H154482667"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>Not all patients with pain following esophageal dilation have a perforation. Nonspecific chest pain following esophageal dilation is not uncommon, though it is typically mild, self-limited, and lacks the associated signs and symptoms seen with a perforation, such as subcutaneous emphysema. An exception is the pain associated with esophageal dilation with stent placement, which may be severe [<a href="#rid25">25-27</a>]. In addition, some patients will complain of abdominal discomfort resulting from air insufflation. Like patients with nonspecific chest pain, the abdominal discomfort is typically mild and transient. (See <a class="local">'Nonspecific chest pain'</a> below.)</p><p>Chest or abdominal pain may also be seen with disorders such as myocardial infarction, pancreatitis, peptic ulcer perforation, aortic aneurysm dissection, spontaneous pneumothorax, or pneumonia. However, the history of a recent esophageal dilation makes these disorders less likely. </p><p>In general, an esophageal perforation should be excluded if the patient's pain is moderate to severe, if it fails to improve after one to two hours, or if there are other symptoms suggestive of a perforation. In addition, patients with post-procedure pain should be given nothing by mouth until it is clear that their pain is improving. (See <a class="local">'Clinical manifestations'</a> above.)</p><p class="headingAnchor" id="H5"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>An esophageal perforation should be suspected in patients who develop significant neck, chest, or abdominal pain following endoscopy. Generally, the evaluation starts with an examination for signs of a perforation (eg, subcutaneous emphysema), followed by plain thoracic and cervical radiographs. If needed, contrast esophagography or computed tomographic (CT) scanning may be obtained to confirm the diagnosis or to look for intrathoracic and intra-abdominal collections that require drainage. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>Because delays in diagnosis are associated with higher complication and mortality rates, early diagnosis is essential [<a href="#rid28">28-30</a>]. As an example, in a summary of 390 patients from 11 series, the overall mortality rate for patients who did not receive treatment within 24 hours was 27 percent (range 0 to 46 percent), whereas it was 14 percent (range 0 to 28 percent) for patients who were treated within 24 hours [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H150633334"><span class="h3">Thoracic and cervical radiographs</span><span class="headingEndMark"> — </span>Patients with a suspected perforation should undergo thoracic and cervical radiographs (posterior-anterior and lateral films). In addition, if an intra-abdominal perforation is suspected, upright abdominal films should be obtained. Radiographic evidence of emphysema is found subcutaneously in the neck in approximately 95 percent of patients with cervical perforations, and in the mediastinum in approximately 40 percent of patients with intrathoracic perforations [<a href="#rid31">31</a>]. Other findings suggestive of an esophageal perforation include pleural effusions, mediastinal widening, hydrothorax, hydropneumothorax, or subdiaphragmatic air. Mediastinal emphysema may not become visible radiographically for an hour, and pleural effusions and mediastinal widening may take several hours to develop [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H150633349"><span class="h3">Contrast esophagography (Gastrografin or barium swallow)</span><span class="headingEndMark"> — </span>Contrast esophagography usually establishes the diagnosis. The sensitivity of contrast studies depends upon the size and location of the perforation, and the technique used for the study. The studies should be carried out with the patient in the right lateral decubitus position [<a href="#rid33">33</a>]. In many centers, water-soluble contrast agents (eg, Gastrografin) are used initially. Esophagography with water-soluble contrast will show extravasation on radiograph in 50 percent of patients with cervical perforations and 75 to 80 of patient with thoracic perforations  (<a class="graphic graphic_diagnosticimage graphicRef71821" href="/d/graphic/71821.html" rel="external">image 1</a>) [<a href="#rid34">34</a>]. Water-soluble contrast must be used with care in patients at risk for aspiration, as it can cause severe pneumonitis. In such patients, dilute <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> is preferred as the initial contrast agent. In addition, water-soluble contrast should not be used in patients with known or suspected fistulas between the esophagus and the respiratory tract or if respiratory tract perforation is suspected.</p><p>If the water-soluble contrast study is negative, a <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> study should be performed. Barium studies will detect 60 percent of cervical perforations and 90 percent of intrathoracic perforations [<a href="#rid31">31,35</a>]. Although barium is superior to water-soluble contrast for demonstrating small perforations, it causes an inflammatory response in mediastinal or pleural cavities and is therefore not used as the primary diagnostic study [<a href="#rid36">36</a>]. </p><p class="headingAnchor" id="H150633364"><span class="h3">Computed tomography</span><span class="headingEndMark"> — </span>If clinical suspicion remains high despite negative findings on esophageal contrast studies, or if contrast studies cannot be obtained, CT scanning should be performed. A CT scan is highly sensitive for detecting extravasated air in soft tissues adjacent to the esophagus or in the mediastinum [<a href="#rid37">37</a>]. Other findings on CT scan may include esophageal wall thickening, pleural effusions, or periesophageal fluid [<a href="#rid37">37</a>]. We agree with the recommendation of some authors that all patients with an esophageal perforation undergo CT scanning to look for intrathoracic and intra-abdominal fluid collections that would require drainage [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H154482778"><span class="h3">Flexible upper endoscopy</span><span class="headingEndMark"> — </span>Upper endoscopy is generally not used to diagnose a perforation following esophageal dilation (though it may be used in other settings where esophageal perforation is suspected, such as penetrating trauma). Air insufflated during endoscopy may dissect intramurally and cause cervical subcutaneous emphysema. This in turn could suggest a more serious perforation than what is actually present and may result in surgery in a patient who could have been managed medically [<a href="#rid2">2</a>]. However, upper endoscopy may be employed as part of the treatment for the perforation (see <a class="local">'Endoscopic management'</a> below).</p><p>If a perforation is clearly seen at the time of the index endoscopy, radiographic imaging should still be obtained to assess the extent of the perforation/leak, or if endoscopic therapy is performed at the time of the perforation, to assess closure of the defect.</p><p class="headingAnchor" id="H27673362"><span class="h2">Management</span><span class="headingEndMark"> — </span>The management of patients with esophageal perforation following esophageal dilation depends upon the severity of the perforation and the elapsed time between the perforation and its diagnosis. Management options include medical management, endoscopic therapy, and surgery.</p><p>Patients whose perforations are recognized early have a good prognosis and, in many cases, can be managed nonsurgically. By contrast, a delay in diagnosis (particularly beyond 24 hours) usually leads to the need for surgical intervention and is associated with a mortality rate as high as 25 to 50 percent [<a href="#rid35">35,39</a>].</p><p>The goals of management are to prevent further contamination, treat infection, restore gastrointestinal tract continuity, and provide nutritional support.</p><p class="headingAnchor" id="H154482785"><span class="h3">General management</span><span class="headingEndMark"> — </span>Because the mortality rate associated with esophageal perforation is high, intensive care unit admission should be considered not only for patients with evidence of hemodynamic compromise, but also for patients with multiple comorbid conditions.</p><p>Regardless of what management approach is chosen (medical, endoscopic, or surgical), all patients with an esophageal perforation require the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Avoidance of all oral intake</p><p class="bulletIndent1"><span class="glyph">●</span>Nutritional support, typically parenteral</p><p class="bulletIndent1"><span class="glyph">●</span>Intravenous broad spectrum antibiotics</p><p class="bulletIndent1"><span class="glyph">●</span>Intravenous proton pump inhibitor</p><p class="bulletIndent1"><span class="glyph">●</span>Drainage of fluid collections/debridement of infected and necrotic tissue if present</p><p></p><p>In addition, surgical consultation should be obtained for all patients, since patients managed medically or endoscopically may deteriorate and require surgical intervention.</p><p class="headingAnchor" id="H6"><span class="h3">Medical management</span></p><p class="headingAnchor" id="H150633261"><span class="h4">Patient selection for medical management</span><span class="headingEndMark"> — </span>Several reports have documented successful nonsurgical management of esophageal perforations in appropriately selected patients [<a href="#rid31">31,35,39-43</a>]. </p><p>Characteristics that are associated with favorable outcomes in patients who are managed nonoperatively include [<a href="#rid38">38</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Iatrogenic perforations, since patients are likely to have taken nothing by mouth prior to the procedure, which limits the amount of gastric contents [<a href="#rid44">44</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Clinically stable patients who are young and healthy</p><p class="bulletIndent1"><span class="glyph">●</span>Patients who present within 24 hours of the perforation, or patients with a delayed presentation who are hemodynamically stable without signs of sepsis</p><p class="bulletIndent1"><span class="glyph">●</span>Cervical esophageal perforations</p><p class="bulletIndent1"><span class="glyph">●</span>Small transmural thoracic perforations with local, circumscribed extravasation of contrast</p><p class="bulletIndent1"><span class="glyph">●</span>Absence of continued extravasation into the mediastinum or pleura and emptying of contrast from the perforation site into the distal esophagus and stomach during contrast esophagography</p><p></p><p>Characteristics associated with poor outcomes include [<a href="#rid38">38</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Sepsis, respiratory failure, and shock</p><p class="bulletIndent1"><span class="glyph">●</span>Intra-abdominal perforations</p><p class="bulletIndent1"><span class="glyph">●</span>Perforations in multiple locations</p><p class="bulletIndent1"><span class="glyph">●</span>Large perforations with widespread contamination</p><p class="bulletIndent1"><span class="glyph">●</span>Perforations involving the pleural cavities</p><p class="bulletIndent1"><span class="glyph">●</span>Perforations with retained foreign bodies</p><p class="bulletIndent1"><span class="glyph">●</span>Perforations within neoplastic tissue</p><p></p><p>Therefore, it is appropriate to consider medical management if all of the following criteria are met [<a href="#rid2">2,43</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The perforation is diagnosed early, or if diagnosed late, the leak is contained</p><p class="bulletIndent1"><span class="glyph">●</span>The leak is contained within the neck or mediastinum or between the mediastinum and visceral lung pleura</p><p class="bulletIndent1"><span class="glyph">●</span>Contrast is able to flow back into the esophagus from the cavity surrounding the perforation</p><p class="bulletIndent1"><span class="glyph">●</span>The injury is not in neoplastic tissue, is not in the abdomen, and is not proximal to an obstruction</p><p class="bulletIndent1"><span class="glyph">●</span>The patient has minimal symptoms</p><p class="bulletIndent1"><span class="glyph">●</span>Signs and symptoms of sepsis are absent</p><p class="bulletIndent1"><span class="glyph">●</span>Access to contrast studies can be obtained at any time of day</p><p class="bulletIndent1"><span class="glyph">●</span>An experienced thoracic surgeon is readily available if the patient deteriorates</p><p></p><p>Patients who do not fulfill these criteria should be considered for surgical management. However, in patients who are deemed to be at high risk for surgical intervention, the risks of surgery need to be weighed against the benefits. In some cases, nonoperative therapy (medical or endoscopic management) may be preferable in such patients. In addition, endoscopic management may be an option for perforations associated with neoplastic tissue. (See <a class="local">'Endoscopic management'</a> below and <a class="local">'Surgical management'</a> below.) </p><p class="headingAnchor" id="H7"><span class="h4">Approach to medical management</span><span class="headingEndMark"> — </span>For patients who are appropriate candidates for medical management, treatment includes [<a href="#rid38">38</a>] (see <a class="local">'Patient selection for medical management'</a> above):</p><p class="bulletIndent1"><span class="glyph">●</span>Avoidance of all oral intake for at least seven days</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">Parenteral nutrition</a> support</p><p class="bulletIndent1"><span class="glyph">●</span>Intravenous broad spectrum antibiotics for 7 to 14 days</p><p class="bulletIndent1"><span class="glyph">●</span>Drainage of fluid collections</p><p></p><p>The role of a nasogastric tube, which may help minimize extravasation of oral secretions through the perforation, is less clear [<a href="#rid39">39</a>]. Some advocate placing a tube above the perforation, others suggest using a tube that crosses the perforation, and others do not use a nasogastric tube at all. However, passage of a tube into the stomach may be dangerous in the setting of a perforation and can lead to the reflux of gastric contents. Because of these risks, we do not place a nasogastric tube for management of esophageal perforation.</p><p>If the patient is improving clinically, a <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> esophagram should be obtained after seven days. Management will then depend upon what is seen:</p><p class="bulletIndent1"><span class="glyph">●</span>If there is no contrast extravasation, clear liquids can be initiated. The diet can then be advanced as tolerated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> esophagram demonstrates that the perforation is still present, but is smaller, then it is reasonable to wait another seven days to allow more time for healing and then repeat the study. At that time, if there is no perforation demonstrated, clear liquids can be initiated and the diet advanced as tolerated. If the perforation is still present after two weeks, we proceed with placement of a removable covered metal stent. (See <a class="local">'Endoscopic management'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the perforation is the same size or larger, then our approach is to place a removable covered metal stent to treat the perforation. (See <a class="local">'Endoscopic management'</a> below.)</p><p></p><p>Patients who show signs of clinical deterioration during medical management require surgical intervention. Surgery is indicated in patients who are being managed medically if any of the following develop [<a href="#rid38">38</a>] (see <a class="local">'Surgical management'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>A perforation that initially had limited extravasation of contrast develops free diffuse extravasation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Extension of the perforation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinical deterioration, persistent fevers, or sepsis (if a collection that is amenable to percutaneous drainage is present then attempted drainage of the collection prior to proceeding with surgery is reasonable)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Progression of pneumomediastinum or pneumothorax</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Development of an empyema</p><p></p><p class="headingAnchor" id="H154483597"><span class="h4">Outcomes with medical management</span><span class="headingEndMark"> — </span>Studies suggest that in appropriately selected patients, medical management can be successful [<a href="#rid45">45-47</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>In a series of 26 patients with iatrogenic perforations who were managed medically, four patients (15 percent) died, and one patient required surgery because of mediastinal soilage and sepsis [<a href="#rid47">47</a>]. Of the patients who died, one had presented more than 24 hours after the perforation, two had perforations in the setting of esophageal cancer, and one was elderly with renal failure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a series of 47 patients with esophageal perforations (25 iatrogenic), all 34 of the patients treated with medical management survived and had documented esophageal healing at the time of discharge [<a href="#rid46">46</a>].</p><p></p><p class="headingAnchor" id="H27673437"><span class="h3">Endoscopic management</span><span class="headingEndMark"> — </span>Removable plastic or fully covered, self-expandable metal stents (FCSEMS) make it possible to treat some patients with esophageal perforations endoscopically, and the rate of stent use appears to be increasing. In a study of 659 patients with benign esophageal perforation, esophageal stents were placed in 100 patients (15 percent), and the rate of stent placement increased from 7 to 30 percent over the eight year duration of the study [<a href="#rid48">48</a>]. </p><p>Stents may be appropriate for patients with perforations in the setting of an esophageal neoplasm [<a href="#rid49">49,50</a>] or for patients who are unlikely to tolerate more extensive surgery, provided an endoscopist who is experienced with esophageal stent placement is available. Multiple series have described the successful use of stents for esophageal perforations, though no large trials have been carried out [<a href="#rid51">51-57</a>]. In one series, 33 patients (19 of whom had an iatrogenic perforation) underwent stenting with removable stents [<a href="#rid51">51</a>]. The stent sealed the lesion in 32 patients (97 percent). Stent extractions were uncomplicated in all 23 patients who had their stents removed within six weeks. Ten patients had their stents removed between 6 and 84 weeks after placement. In that group, there were six extraction-related complications. Ultimately, four patients (12 percent) required an esophageal resection. For three patients, it was due to failed stent therapy, and in one it was due to failed stent removal. </p><p>Covered stents have been associated with risk of stent migration [<a href="#rid58">58</a>]. Most advanced endoscopists anchor FCSEMS in the esophagus to decrease the risk of migration. Anchoring methods include suturing or placing a special over-the-scope clip device that is designed specifically for use with FCSEMS [<a href="#rid59">59</a>].  </p><p>If an esophageal stent is used, a repeat esophagram should be obtained in one to two days to document that the perforation has sealed [<a href="#rid38">38</a>]. Once confirmed, the patient may resume oral intake (typically clear liquids to start, with advancement of the diet as tolerated). If stent migration occurs, an attempt to reposition or to replace the stent is reasonable [<a href="#rid38">38</a>]. </p><p>The optimal amount of time to leave the stent in place has not been established. Stents are often removed six to eight weeks following insertion, but the longer the stent is left in place, the more likely that granulation tissue may develop that may make stent removal difficult. There are reports of removal in as few as 10 to 21 days with complete healing of the perforation [<a href="#rid50">50,52,53</a>]. In patients being treated with a stent, we suggest removal within six weeks of placement. </p><p>There have also been reports suggesting that endoscopic clips may be used to treat patients who have acute esophageal perforations due to therapeutic endoscopy, provided there is no evidence of significant extraesophageal contamination [<a href="#rid60">60-66</a>]. An over-the-scope-clip system (OTSC) has been used successfully to close perforations. The OTSC system appears to be a safe and effective method [<a href="#rid67">67</a>]. However, until more data become available, we suggest that endoscopic clips only be used to close perforations in the setting of clinical trials by endoscopists who are highly skilled in their use.</p><p class="headingAnchor" id="H250904539"><span class="h3">Surgical management</span><span class="headingEndMark"> — </span>Patients who are not candidates for or who fail conservative attempts at treatment require surgical treatment. This can include primary repair of the defect, resection of the defect, diversion, drainage of collections, or in some cases, esophagectomy. The surgical approach is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/15066.html" rel="external">"Surgical management of esophageal perforation"</a>.)</p><p class="headingAnchor" id="H154484442"><span class="h1">NONSPECIFIC CHEST PAIN</span><span class="headingEndMark"> — </span>Chest pain is sometimes observed following stricture dilation, even in patients without a perforation. This nonspecific chest pain is usually mild, self-limited, and requires no specific therapy. Rare patients require a period of a liquid diet and/or analgesics. Chest pain following dilation is commonly observed in patients with eosinophilic esophagitis in whom even gentle dilation can cause mucosal tearing and/or perforation. It is also relatively common when dilation is followed by placement of an expandable stent. (See  <a class="medical medical_review" href="/d/html/2677.html" rel="external">"Endoscopic stenting for palliation of malignant esophageal obstruction"</a> and  <a class="medical medical_review" href="/d/html/2247.html" rel="external">"Treatment of eosinophilic esophagitis (EoE)", section on 'Esophageal dilation'</a>.)</p><p>An esophageal perforation should be excluded if the patient's pain is moderate to severe, if it fails to improve after one to two hours, or if there are other symptoms suggestive of a perforation. In addition, patients with post-procedure pain should be given nothing by mouth until it is clear that their pain is improving. (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p class="headingAnchor" id="H8"><span class="h1">BACTEREMIA</span><span class="headingEndMark"> — </span>Esophageal dilation has the highest incidence of bacteremia of all gastrointestinal endoscopic procedures, occurring in approximately 45 percent of cases [<a href="#rid68">68</a>]. In spite of this, complications of bacteremia such as endocarditis are rare [<a href="#rid69">69</a>]. A survey performed in 1976 found only two cases of endocarditis in over 23,000 dilations [<a href="#rid3">3</a>].</p><p>Guidelines for antibiotic prophylaxis have been established by the American Society for Gastrointestinal Endoscopy [<a href="#rid70">70</a>] and the American Heart Association  (<a class="graphic graphic_table graphicRef51133" href="/d/graphic/51133.html" rel="external">table 1</a>). The guidelines do not recommend antibiotic prophylaxis for esophageal dilation. (See  <a class="medical medical_review" href="/d/html/2545.html" rel="external">"Antibiotic prophylaxis for gastrointestinal endoscopic procedures"</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">HEMORRHAGE</span><span class="headingEndMark"> — </span>Significant hemorrhage related to esophageal dilation is uncommon. In one series, hemorrhage requiring blood transfusions occurred in 0.2 percent of esophageal dilations with mechanical dilators [<a href="#rid3">3</a>]. Another series found significant hemorrhage in 2 percent of patients who underwent balloon dilation [<a href="#rid71">71</a>]. However, subsequent series suggested that the incidence of hemorrhage is infrequent, regardless of the type of dilator used [<a href="#rid72">72,73</a>].</p><p>Endoscopic evaluation and therapy are not required in a hemodynamically stable patient with a small amount of hematemesis or coffee ground emesis. However, patients with ongoing bleeding, hemodynamic instability, or a drop in hematocrit should undergo endoscopy for evaluation and treatment. (See  <a class="medical medical_review" href="/d/html/2548.html" rel="external">"Approach to acute upper gastrointestinal bleeding in adults"</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">COMPLICATIONS RELATED TO ENDOSCOPY</span><span class="headingEndMark"> — </span>Complications associated with procedural sedation and the endoscopy itself include aspiration pneumonia, respiratory failure, and cardiac arrhythmias [<a href="#rid3">3,74</a>]. (See  <a class="medical medical_review" href="/d/html/2567.html" rel="external">"Gastrointestinal endoscopy in adults: Procedural sedation administered by endoscopists", section on 'Adverse events'</a> and  <a class="medical medical_review" href="/d/html/13928.html" rel="external">"Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)", section on 'Complications'</a>.)</p><p class="headingAnchor" id="H13"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>The major complication of esophageal dilation is esophageal perforation, which is associated with a mortality rate of approximately 20 percent. The incidence of perforation is influenced by the etiology of the stricture, the experience of the endoscopist, and the techniques and equipment used. In general, perforation rates associated with benign esophageal stricture dilation are low (one to two per thousand). (See <a class="local">'Esophageal perforation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The clinical manifestations of esophageal perforation may include neck, chest, or back pain, hoarseness, dysphagia, odynophagia, dyspnea, hematemesis, subcutaneous emphysema, and symptoms of an acute abdomen. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of an esophageal perforation is based upon recognition of the clinical features and radiographic evaluation. The diagnosis should be suspected in patients who develop significant neck, chest, or abdominal pain following endoscopy. Generally, the evaluation starts with plain thoracic and cervical radiographs. If needed, contrast esophagography or computed tomographic (CT) scanning may be obtained to confirm the diagnosis or to look for intrathoracic and intra-abdominal collections that require drainage. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The management of patients with esophageal perforation following esophageal dilation depends upon the severity of the perforation and the elapsed time between the perforation and its diagnosis. Management options include medical management, endoscopic therapy, and surgery. (See <a class="local">'Management'</a> above.)</p><p></p><p class="bulletIndent1">Regardless of what management approach is chosen, all patients with an esophageal perforation require the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoidance of all oral intake</p><p class="bulletIndent2"><span class="glyph">•</span>Nutritional support, typically parenteral</p><p class="bulletIndent2"><span class="glyph">•</span>Intravenous broad spectrum antibiotics </p><p class="bulletIndent2"><span class="glyph">•</span>Intravenous proton pump inhibitor</p><p class="bulletIndent2"><span class="glyph">•</span>Drainage of fluid collections/debridement of infected and necrotic tissue if present</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chest pain is sometimes observed following stricture dilation, even in patients without a perforation. It is usually mild, self-limited, and requires no specific therapy. However, an esophageal perforation should be excluded if the patient's pain is moderate to severe, if it fails to improve after one to two hours, or if there are other symptoms suggestive of a perforation. In addition, patients with post-procedure pain should be given nothing by mouth until it is clear that their pain is improving. (See <a class="local">'Nonspecific chest pain'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other uncommon complications of esophageal stricture dilation include bacteremia and hemorrhage. (See <a class="local">'Bacteremia'</a> above and <a class="local">'Hemorrhage'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Standards of Practice Committee, Egan JV, Baron TH, et al. Esophageal dilation. Gastrointest Endosc 2006; 63:755.</a></li><li><a class="nounderline abstract_t">Brinster CJ, Singhal S, Lee L, et al. Evolving options in the management of esophageal perforation. Ann Thorac Surg 2004; 77:1475.</a></li><li><a class="nounderline abstract_t">Mandelstam P, Sugawa C, Silvis SE, et al. Complications associated with esophagogastroduodenoscopy and with esophageal dilation. Gastrointest Endosc 1976; 23:16.</a></li><li><a class="nounderline abstract_t">Pereira-Lima JC, Ramires RP, Zamin I Jr, et al. Endoscopic dilation of benign esophageal strictures: report on 1043 procedures. Am J Gastroenterol 1999; 94:1497.</a></li><li><a class="nounderline abstract_t">Hernandez LV, Jacobson JW, Harris MS. Comparison among the perforation rates of Maloney, balloon, and savary dilation of esophageal strictures. Gastrointest Endosc 2000; 51:460.</a></li><li><a class="nounderline abstract_t">Piotet E, Escher A, Monnier P. Esophageal and pharyngeal strictures: report on 1,862 endoscopic dilatations using the Savary-Gilliard technique. Eur Arch Otorhinolaryngol 2008; 265:357.</a></li><li><a class="nounderline abstract_t">Karnak I, Tanyel FC, Büyükpamukçu N, Hiçsönmez A. Esophageal perforations encountered during the dilation of caustic esophageal strictures. J Cardiovasc Surg (Torino) 1998; 39:373.</a></li><li><a class="nounderline abstract_t">Silvis SE, Nebel O, Rogers G, et al. Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA 1976; 235:928.</a></li><li><a class="nounderline abstract_t">Petersen JF, Pézier TF, van Dieren JM, et al. Dilation after laryngectomy: Incidence, risk factors and complications. Oral Oncol 2019; 91:107.</a></li><li><a class="nounderline abstract_t">Nostrant TT, Nandi PS. Esophageal dilation. Gastroenterologist 1998; 6:5.</a></li><li><a class="nounderline abstract_t">Marshall JB, Afridi SA, King PD, et al. Esophageal dilation with polyvinyl (American) dilators over a marked guidewire: practice and safety at one center over a 5-yr period. Am J Gastroenterol 1996; 91:1503.</a></li><li><a class="nounderline abstract_t">Tucker LE. Esophageal stricture: results of dilation of 300 patients. Mo Med 1992; 89:668.</a></li><li><a class="nounderline abstract_t">Swaroop VS, Desai DC, Mohandas KM, et al. Dilation of esophageal strictures induced by radiation therapy for cancer of the esophagus. Gastrointest Endosc 1994; 40:311.</a></li><li><a class="nounderline abstract_t">Bush N, Bhattacharjee S, Sachan A, et al. Perforations from Endoscopic Dilation of Corrosive Strictures in Adults: A Systematic Review and Meta-Analysis. Dig Dis Sci 2022; 67:3200.</a></li><li><a class="nounderline abstract_t">Kaplan M, Mutlu EA, Jakate S, et al. Endoscopy in eosinophilic esophagitis: "feline" esophagus and perforation risk. Clin Gastroenterol Hepatol 2003; 1:433.</a></li><li><a class="nounderline abstract_t">Jung KW, Gundersen N, Kopacova J, et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc 2011; 73:15.</a></li><li><a class="nounderline abstract_t">Cohen MS, Kaufman AB, Palazzo JP, et al. An audit of endoscopic complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol 2007; 5:1149.</a></li><li><a class="nounderline abstract_t">Eisenbach C, Merle U, Schirmacher P, et al. Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis. Endoscopy 2006; 38 Suppl 2:E43.</a></li><li><a class="nounderline abstract_t">Dougherty M, Runge TM, Eluri S, Dellon ES. Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis. Gastrointest Endosc 2017; 86:581.</a></li><li><a class="nounderline abstract_t">Jacobs JW Jr, Spechler SJ. A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis. Dig Dis Sci 2010; 55:1512.</a></li><li><a class="nounderline abstract_t">Kavic SM, Basson MD. Complications of endoscopy. Am J Surg 2001; 181:319.</a></li><li><a class="nounderline abstract_t">Søreide JA, Viste A. Esophageal perforation: diagnostic work-up and clinical decision-making in the first 24 hours. Scand J Trauma Resusc Emerg Med 2011; 19:66.</a></li><li><a class="nounderline abstract_t">Attar S, Hankins JR, Suter CM, et al. Esophageal perforation: a therapeutic challenge. Ann Thorac Surg 1990; 50:45.</a></li><li><a class="nounderline abstract_t">Maher MM, Lucey BC, Boland G, et al. The role of interventional radiology in the treatment of mediastinal collections caused by esophageal anastomotic leaks. AJR Am J Roentgenol 2002; 178:649.</a></li><li><a class="nounderline abstract_t">Holm AN, de la Mora Levy JG, Gostout CJ, et al. Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc 2008; 67:20.</a></li><li><a class="nounderline abstract_t">Dua KS, Vleggaar FP, Santharam R, Siersema PD. Removable self-expanding plastic esophageal stent as a continuous, non-permanent dilator in treating refractory benign esophageal strictures: a prospective two-center study. Am J Gastroenterol 2008; 103:2988.</a></li><li><a class="nounderline abstract_t">Kim JH, Song HY, Choi EK, et al. Temporary metallic stent placement in the treatment of refractory benign esophageal strictures: results and factors associated with outcome in 55 patients. Eur Radiol 2009; 19:384.</a></li><li><a class="nounderline abstract_t">White RK, Morris DM. Diagnosis and management of esophageal perforations. Am Surg 1992; 58:112.</a></li><li><a class="nounderline abstract_t">Reeder LB, DeFilippi VJ, Ferguson MK. Current results of therapy for esophageal perforation. Am J Surg 1995; 169:615.</a></li><li><a class="nounderline abstract_t">Sawyer R, Phillips C, Vakil N. Short- and long-term outcome of esophageal perforation. Gastrointest Endosc 1995; 41:130.</a></li><li><a class="nounderline abstract_t">Sarr MG, Pemberton JH, Payne WS. Management of instrumental perforations of the esophagus. J Thorac Cardiovasc Surg 1982; 84:211.</a></li><li><a class="nounderline abstract_t">Han SY, McElvein RB, Aldrete JS, Tishler JM. Perforation of the esophagus: correlation of site and cause with plain film findings. AJR Am J Roentgenol 1985; 145:537.</a></li><li class="breakAll">Peter P Lopez. Complications of esophageal surgery and trauma. In: Complications in srugery and trauma, Stephen M. Cohn (Ed), Informa Healthcare USA, Inc., New York 2007. p.257.</li><li><a class="nounderline abstract_t">Foley MJ, Ghahremani GG, Rogers LF. Reappraisal of contrast media used to detect upper gastrointestinal perforations: comparison of ionic water-soluble media with barium sulfate. Radiology 1982; 144:231.</a></li><li><a class="nounderline abstract_t">Bladergroen MR, Lowe JE, Postlethwait RW. Diagnosis and recommended management of esophageal perforation and rupture. Ann Thorac Surg 1986; 42:235.</a></li><li><a class="nounderline abstract_t">Dodds WJ, Stewart ET, Vlymen WJ. Appropriate contrast media for evaluation of esophageal disruption. Radiology 1982; 144:439.</a></li><li><a class="nounderline abstract_t">White CS, Templeton PA, Attar S. Esophageal perforation: CT findings. AJR Am J Roentgenol 1993; 160:767.</a></li><li><a class="nounderline abstract_t">Madanick RD. Medical management of iatrogenic esophageal perforations. Curr Treat Options Gastroenterol 2008; 11:54.</a></li><li><a class="nounderline abstract_t">Shaffer HA Jr, Valenzuela G, Mittal RK. Esophageal perforation. A reassessment of the criteria for choosing medical or surgical therapy. Arch Intern Med 1992; 152:757.</a></li><li><a class="nounderline abstract_t">Mengoli LR, Klassen KP. Conservative management of esophageal perforation. Arch Surg 1965; 91:238.</a></li><li><a class="nounderline abstract_t">Lyons WS, Seremetis MG, deGuzman VC, Peabody JW Jr. Ruptures and perforations of the esophagus: the case for conservative supportive management. Ann Thorac Surg 1978; 25:346.</a></li><li><a class="nounderline abstract_t">Cameron JL, Kieffer RF, Hendrix TR, et al. Selective nonoperative management of contained intrathoracic esophageal disruptions. Ann Thorac Surg 1979; 27:404.</a></li><li><a class="nounderline abstract_t">Altorjay A, Kiss J, Vörös A, Bohák A. Nonoperative management of esophageal perforations. Is it justified? Ann Surg 1997; 225:415.</a></li><li><a class="nounderline abstract_t">Hauge T, Kleven OC, Johnson E, et al. Outcome after iatrogenic esophageal perforation. Scand J Gastroenterol 2019; 54:140.</a></li><li><a class="nounderline abstract_t">Martinez L, Rivas S, Hernández F, et al. Aggressive conservative treatment of esophageal perforations in children. J Pediatr Surg 2003; 38:685.</a></li><li><a class="nounderline abstract_t">Vogel SB, Rout WR, Martin TD, Abbitt PL. Esophageal perforation in adults: aggressive, conservative treatment lowers morbidity and mortality. Ann Surg 2005; 241:1016.</a></li><li><a class="nounderline abstract_t">Hasan S, Jilaihawi AN, Prakash D. Conservative management of iatrogenic oesophageal perforations--a viable option. Eur J Cardiothorac Surg 2005; 28:7.</a></li><li><a class="nounderline abstract_t">Thornblade LW, Cheng AM, Wood DE, et al. A Nationwide Rise in the Use of Stents for Benign Esophageal Perforation. Ann Thorac Surg 2017; 104:227.</a></li><li><a class="nounderline abstract_t">White RE, Mungatana C, Topazian M. Expandable stents for iatrogenic perforation of esophageal malignancies. J Gastrointest Surg 2003; 7:715.</a></li><li><a class="nounderline abstract_t">Johnsson E, Lundell L, Liedman B. Sealing of esophageal perforation or ruptures with expandable metallic stents: a prospective controlled study on treatment efficacy and limitations. Dis Esophagus 2005; 18:262.</a></li><li><a class="nounderline abstract_t">van Heel NC, Haringsma J, Spaander MC, et al. Short-term esophageal stenting in the management of benign perforations. Am J Gastroenterol 2010; 105:1515.</a></li><li><a class="nounderline abstract_t">Fischer A, Thomusch O, Benz S, et al. Nonoperative treatment of 15 benign esophageal perforations with self-expandable covered metal stents. Ann Thorac Surg 2006; 81:467.</a></li><li><a class="nounderline abstract_t">Freeman RK, Van Woerkom JM, Ascioti AJ. Esophageal stent placement for the treatment of iatrogenic intrathoracic esophageal perforation. Ann Thorac Surg 2007; 83:2003.</a></li><li><a class="nounderline abstract_t">Salminen P, Gullichsen R, Laine S. Use of self-expandable metal stents for the treatment of esophageal perforations and anastomotic leaks. Surg Endosc 2009; 23:1526.</a></li><li><a class="nounderline abstract_t">Schmidt SC, Strauch S, Rösch T, et al. Management of esophageal perforations. Surg Endosc 2010; 24:2809.</a></li><li><a class="nounderline abstract_t">Kiev J, Amendola M, Bouhaidar D, et al. A management algorithm for esophageal perforation. Am J Surg 2007; 194:103.</a></li><li><a class="nounderline abstract_t">Leers JM, Vivaldi C, Schäfer H, et al. Endoscopic therapy for esophageal perforation or anastomotic leak with a self-expandable metallic stent. Surg Endosc 2009; 23:2258.</a></li><li><a class="nounderline abstract_t">Fuccio L, Hassan C, Frazzoni L, et al. Clinical outcomes following stent placement in refractory benign esophageal stricture: a systematic review and meta-analysis. Endoscopy 2016; 48:141.</a></li><li><a class="nounderline abstract_t">Conio M, Savarese MF, Baron TH, et al. A newly designed over-the-scope-clip device to prevent fully covered metal stents migration: A pilot study. Tech Innov Gastrointest Endosc 2020; 22:167.</a></li><li><a class="nounderline abstract_t">Qadeer MA, Dumot JA, Vargo JJ, et al. Endoscopic clips for closing esophageal perforations: case report and pooled analysis. Gastrointest Endosc 2007; 66:605.</a></li><li><a class="nounderline abstract_t">Raju GS, Thompson C, Zwischenberger JB. Emerging endoscopic options in the management of esophageal leaks (videos). Gastrointest Endosc 2005; 62:278.</a></li><li><a class="nounderline abstract_t">Wewalka FW, Clodi PH, Haidinger D. Endoscopic clipping of esophageal perforation after pneumatic dilation for achalasia. Endoscopy 1995; 27:608.</a></li><li><a class="nounderline abstract_t">Cipolletta L, Bianco MA, Rotondano G, et al. Endoscopic clipping of perforation following pneumatic dilation of esophagojejunal anastomotic strictures. Endoscopy 2000; 32:720.</a></li><li><a class="nounderline abstract_t">Abe N, Sugiyama M, Hashimoto Y, et al. Endoscopic nasomediastinal drainage followed by clip application for treatment of delayed esophageal perforation with mediastinitis. Gastrointest Endosc 2001; 54:646.</a></li><li><a class="nounderline abstract_t">Shimizu Y, Kato M, Yamamoto J, et al. Endoscopic clip application for closure of esophageal perforations caused by EMR. Gastrointest Endosc 2004; 60:636.</a></li><li><a class="nounderline abstract_t">Gerke H, Crowe GC, Iannettoni MD. Endoscopic closure of cervical esophageal perforation caused by traumatic insertion of a mucosectomy cap. Ann Thorac Surg 2007; 84:296.</a></li><li><a class="nounderline abstract_t">Weiland T, Fehlker M, Gottwald T, Schurr MO. Performance of the OTSC System in the endoscopic closure of iatrogenic gastrointestinal perforations: a systematic review. Surg Endosc 2013; 27:2258.</a></li><li><a class="nounderline abstract_t">Botoman VA, Surawicz CM. Bacteremia with gastrointestinal endoscopic procedures. Gastrointest Endosc 1986; 32:342.</a></li><li><a class="nounderline abstract_t">Niv Y, Bat L, Motro M. Bacterial endocarditis after Hurst bougienage in a patient with a benign esophageal stricture and mitral valve prolapse. Gastrointest Endosc 1985; 31:265.</a></li><li><a class="nounderline abstract_t">Antibiotic prophylaxis for gastrointestinal endoscopy. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 1995; 42:630.</a></li><li><a class="nounderline abstract_t">Kozarek RA. Hydrostatic balloon dilation of gastrointestinal stenoses: a national survey. Gastrointest Endosc 1986; 32:15.</a></li><li><a class="nounderline abstract_t">Shemesh E, Czerniak A. Comparison between Savary-Gilliard and balloon dilatation of benign esophageal strictures. World J Surg 1990; 14:518.</a></li><li><a class="nounderline abstract_t">Saeed ZA, Winchester CB, Ferro PS, et al. Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus. Gastrointest Endosc 1995; 41:189.</a></li><li><a class="nounderline abstract_t">Lanza FL, Graham DY. Bougienage is effective therapy for most benign esophageal strictures. JAMA 1978; 240:844.</a></li></ol></div><div id="topicVersionRevision">Topic 2275 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16650533" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Esophageal dilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15063302" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Evolving options in the management of esophageal perforation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1085713" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Complications associated with esophagogastroduodenoscopy and with esophageal dilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10364013" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Endoscopic dilation of benign esophageal strictures: report on 1043 procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10744819" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Comparison among the perforation rates of Maloney, balloon, and savary dilation of esophageal strictures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17899143" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Esophageal and pharyngeal strictures: report on 1,862 endoscopic dilatations using the Savary-Gilliard technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9678565" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Esophageal perforations encountered during the dilation of caustic esophageal strictures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/128642" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30926055" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Dilation after laryngectomy: Incidence, risk factors and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9531111" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Esophageal dilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8759650" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Esophageal dilation with polyvinyl (American) dilators over a marked guidewire: practice and safety at one center over a 5-yr period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1406561" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Esophageal stricture: results of dilation of 300 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7520011" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Dilation of esophageal strictures induced by radiation therapy for cancer of the esophagus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34739625" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Perforations from Endoscopic Dilation of Corrosive Strictures in Adults: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15017642" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Endoscopy in eosinophilic esophagitis: "feline" esophagus and perforation risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21067739" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17683993" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : An audit of endoscopic complications in adult eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17123211" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28461094" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20238250" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11438266" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Complications of endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22035338" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Esophageal perforation: diagnostic work-up and clinical decision-making in the first 24 hours.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2369229" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Esophageal perforation: a therapeutic challenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11856691" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The role of interventional radiology in the treatment of mediastinal collections caused by esophageal anastomotic leaks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17945227" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Self-expanding plastic stents in treatment of benign esophageal conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18786110" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Removable self-expanding plastic esophageal stent as a continuous, non-permanent dilator in treating refractory benign esophageal strictures: a prospective two-center study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18726598" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Temporary metallic stent placement in the treatment of refractory benign esophageal strictures: results and factors associated with outcome in 55 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1550302" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Diagnosis and management of esophageal perforations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7771627" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Current results of therapy for esophageal perforation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7720999" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Short- and long-term outcome of esophageal perforation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7098508" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Management of instrumental perforations of the esophagus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3875257" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Perforation of the esophagus: correlation of site and cause with plain film findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3875257" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Perforation of the esophagus: correlation of site and cause with plain film findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7089273" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Reappraisal of contrast media used to detect upper gastrointestinal perforations: comparison of ionic water-soluble media with barium sulfate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3753071" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Diagnosis and recommended management of esophageal perforation and rupture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7089304" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Appropriate contrast media for evaluation of esophageal disruption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8456662" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Esophageal perforation: CT findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21063864" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Medical management of iatrogenic esophageal perforations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1558433" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Esophageal perforation. A reassessment of the criteria for choosing medical or surgical therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Conservative management of esophageal perforation</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/637611" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Ruptures and perforations of the esophagus: the case for conservative supportive management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/110275" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Selective nonoperative management of contained intrathoracic esophageal disruptions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9114801" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Nonoperative management of esophageal perforations. Is it justified?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30857441" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Outcome after iatrogenic esophageal perforation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12720170" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Aggressive conservative treatment of esophageal perforations in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15912051" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Esophageal perforation in adults: aggressive, conservative treatment lowers morbidity and mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15923117" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Conservative management of iatrogenic oesophageal perforations--a viable option.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28577842" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : A Nationwide Rise in the Use of Stents for Benign Esophageal Perforation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13129545" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Expandable stents for iatrogenic perforation of esophageal malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16128784" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Sealing of esophageal perforation or ruptures with expandable metallic stents: a prospective controlled study on treatment efficacy and limitations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20234349" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Short-term esophageal stenting in the management of benign perforations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16427833" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Nonoperative treatment of 15 benign esophageal perforations with self-expandable covered metal stents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17532387" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Esophageal stent placement for the treatment of iatrogenic intrathoracic esophageal perforation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19301070" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Use of self-expandable metal stents for the treatment of esophageal perforations and anastomotic leaks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20428896" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Management of esophageal perforations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17560919" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A management algorithm for esophageal perforation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19184216" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Endoscopic therapy for esophageal perforation or anastomotic leak with a self-expandable metallic stent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26528754" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clinical outcomes following stent placement in refractory benign esophageal stricture: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : A newly designed over-the-scope-clip device to prevent fully covered metal stents migration: A pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17725956" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Endoscopic clips for closing esophageal perforations: case report and pooled analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16046996" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Emerging endoscopic options in the management of esophageal leaks (videos).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8608757" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Endoscopic clipping of esophageal perforation after pneumatic dilation for achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10989998" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Endoscopic clipping of perforation following pneumatic dilation of esophagojejunal anastomotic strictures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11677490" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Endoscopic nasomediastinal drainage followed by clip application for treatment of delayed esophageal perforation with mediastinitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15472698" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Endoscopic clip application for closure of esophageal perforations caused by EMR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17588444" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Endoscopic closure of cervical esophageal perforation caused by traumatic insertion of a mucosectomy cap.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23340813" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Performance of the OTSC System in the endoscopic closure of iatrogenic gastrointestinal perforations: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3533703" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Bacteremia with gastrointestinal endoscopic procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4029575" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Bacterial endocarditis after Hurst bougienage in a patient with a benign esophageal stricture and mitral valve prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8674948" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Antibiotic prophylaxis for gastrointestinal endoscopy. American Society for Gastrointestinal Endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3512358" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Hydrostatic balloon dilation of gastrointestinal stenoses: a national survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2382455" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Comparison between Savary-Gilliard and balloon dilatation of benign esophageal strictures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7789675" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/671729" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Bougienage is effective therapy for most benign esophageal strictures.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
